Sreetama Dutt is a news curator and columnist at Multiple Sclerosis News Today. She studied biotechnology at SRM Institute of Science and Technology, and did her Masters in medical microbiology at University of Manchester in Manchester, UK.
Actelion Pharma recently announced that it will accelerate the launch of clinical trials involving its lead drug candidate ponesimod, an oral, selective sphingosine-1-phosphate (S1P1). This decision came after ... Read more
Inovio Pharmaceuticals, a drug development company working on treatments that modulate therapeutically important immune responses with the help of T-cells, recently acquired the worldwide rights (apart ... Read more
Positive study results from a preliminary phase II clinical trial for a new potential therapeutic intervention for the treatment of patients with relapsing remitting multiple sclerosis (RRMS) ... Read more
A small scale study undertaken by researchers at the Department of Neurology, Oregon Health & Science University (OSHU) showed the benefits of maintaining a low-fat diet ... Read more
Pin It on Pinterest